Herpes simplex virus (HSV) is an alpha herpes virus, with two subtypes: HSV-1 and HSV-2.
HSV is one of the most prevalent sexually transmitted infections. It is the cause of severe …

Herpes simplex virus (HSV) infection, the most prevalent viral infection that typically lasts for
a lifetime, is associated with frequent outbreaks of oral and genital lesions. Oral herpes …

HSV-1 causes 50% of first-time genital herpes infections in resource-rich countries and
affects 190 million people worldwide. A prophylactic herpes vaccine is needed to protect …

Discovery and development of novel adjuvants that can improve existing or next generation
vaccine platforms have received considerable interest in recent years. In particular …

Herpes simplex virus type 1 (HSV-1) and herpes simplex virus type 2 (HSV-2) are two of the
most prevalent human viruses worldwide. They are known to cause a variety of diseases …

Introduction Vaccine development for the disease caused by the herpes simplex virus (HSV)
has been challenging over the years and is always in dire need of novel approaches for …

Genital herpes is a venereal disease caused by herpes simplex virus (HSV). Although HSV
symptoms can be reduced with antiviral drugs, there is no cure. Moreover, because HSV …

Alpha herpes simplex viruses are an important public health problem affecting all age
groups. It can produce from common cold sores and chicken pox to severe conditions like …

Research is underway to develop a vaccine to prevent and cure infection from herpes
simplex virus (HSV). It emphasizes the critical need for immunization to address public …

Using the envelope glycoprotein B (gB) crystal structure and digital prediction algorithm, the
B-and T-cell antigenic determinants (epitopes) of human herpesvirus 1 (HHV-1), also known …